Where does University of Vienna rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), University of Vienna ranks #4,989 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does University of Vienna hold?

University of Vienna holds 70 US utility patents granted between 2017 and 2025, spanning 22 technology areas.

What is University of Vienna's Innovation Score?

University of Vienna has an Innovation Score of 48.8 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does University of Vienna focus on?

University of Vienna's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 62 patents, ranking #273 of 6,058 assignees active in that subclass. Grants appear in 22 CPC subclasses total.

Is University of Vienna's patent grant rate increasing or decreasing?

University of Vienna's recent grant velocity is +72% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for University of Vienna's patents?

University of Vienna's patents average 36.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the University of Vienna patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

University of Vienna

USPTO PatentsView assignee record - 70 granted patents across 22 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, University ranks #4,989 of 49,997 tracked US assignees by granted-patent volume, with 70 patents across 22 technology areas.

#4,989
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.8/100): 36.2
avg claims per patent: +72%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4989 · Foreign Corporation #4,989 · 70 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 70 grants
TOP-DECILE #4,989/49,997
PHOTO-FINISH St Jude Medical…
CPC-FOCUS A61P · 22 areas
INNOV-PAR 48.8/100
CLAIMS-DENSE 36.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +72% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: St. Jude Medical Puerto Rico LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How University’s 48.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.7 pts (30%) Velocity 2.5 pts (5%) Breadth 16.6 pts (34%) Claim depth 15.0 pts (31%)

Qualcomm Incorporated · highest

85
Industry-academia… · near

49
Montage Technology · near

49
Soken · near

49
Twist Bioscience · near

49
University of Vienna · this assignee

49
3D Lighting… · lowest

7

What this shows University's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for University?

Each dot is one of University’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). University’s own 36.2 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

University vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where University's grants concentrate

University of Vienna is a focused PatentsView assignee: 22 CPC subclasses with 88.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (19 grants) versus a trough of 1 in 2017. By volume, University sits between St. Jude Medical Puerto Rico LLC and ALi Corporation.

University's three-year grant acceleration

From 2019–2021 to 2022–2024, University of Vienna moved from 45 to 17 grants (0.38x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

St Jude Medical P…

70
Stellenbosch Univ…

70
Techtronic Indust…

70
Ty-flot

70
Veltek Associates

70
Wabtec Holding

70
Wickr

70
University of Vie… ◀

70
Ali

69

What this shows University holds 70 patents at rank #4,989, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near University

By rank, the assignees closest to #4,989 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in University's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for University, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), University ranks #273 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Industry-academia Cooperation Group OF Sejong University 49 Twist Bioscience Corporation 49 Soken, Inc. 49 Montage Technology, Inc. 49

Similar claim depth

Nearest assignees by average claims per patent (36.2 here).

AEye, Inc. 36.4 avg Seagen Inc. 36.8 avg Narrative Science LLC 37.2 avg Monosol, LLC 35.1 avg

University's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

University of Vienna patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	1.4%
2018	5	7.1%
2019	19	27.1%
2020	16	22.9%
2021	10	14.3%
2022	8	11.4%
2023	4	5.7%
2024	5	7.1%
2025partial year	2	2.9%

Which technologies does University of Vienna patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 62

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 62

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 62

C12Y - Enzymes 61

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 61

Y02A - Technologies FOR Adaptation TO Climate Change 61

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 61

H01L - Semiconductor Devices NOT Covered BY Class H10 61

H10H - Inorganic Light-emitting Semiconductor Devices Having Potential Barriers 61

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 61

G02B - Optical Elements, Systems OR Apparatus 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

A61B - DIAGNOSIS; SURGERY; Identification 2

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 2

G02F - Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optical Logic ELEMENTS; Optical ANALOGUE/DIGITAL Converters 1

Top 15 of 22 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

University of Vienna's patent record in context - here's where to go next.

University of Vienna's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 88.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #4,989 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare University of Vienna against St. Jude Medical Puerto Rico LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.